Human FGF-17 Protein, His Tag (HPLC verified)
分子別名(Synonym)
FGF-17,Fibroblast growth factor 17,FGF17
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human FGF-17 Protein, His Tag (FG7-H5144) is expressed from E. coli cells. It contains AA Thr 23 - Thr 216 (Accession # O60258-1).
Predicted N-terminus: Met
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the N-terminus.
The protein has a calculated MW of 24.5 kDa. The protein migrates as 28-30 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under non-reducing (NR) condition (SDS-PAGE).
內(nèi)毒素(Endotoxin)
Less than 0.1 EU per μg by the LAL method.
宿主蛋白殘留(Host Cell Protein)
<0.5 ng/μg of protein tested by ELISA.
宿主核酸殘留(Host Cell DNA)
<0.02 ng/μg of protein tested by qPCR.
無(wú)菌(Sterility)
Negative
支原體(Mycoplasma)
Negative.
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-HPLC.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
成纖維細(xì)胞生長(zhǎng)因子(FGF)是一個(gè)結(jié)構(gòu)相關(guān)的蛋白質(zhì)大家族,參與多種細(xì)胞過(guò)程,包括增殖、分化、遷移和凋亡。FGF17,也稱(chēng)為FGF-13,在胚胎發(fā)生過(guò)程中以及在成年小腦和皮質(zhì)中表達(dá),可能對(duì)血管生長(zhǎng)和正常大腦發(fā)育至關(guān)重要。此外,FGF17和FGF8是小腦發(fā)育各個(gè)階段中后腦區(qū)域模式化的關(guān)鍵因素,具有復(fù)雜的時(shí)空基因表達(dá)圖。
關(guān)鍵字: FGF17;FGF17蛋白;FGF17重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶(hù)超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。